Exercise intolerance is an important predictor of mortality in patients with COPD, and evidence shows reduced nitric oxide (NO) bioavailability is a contributing factor. Thus, restoration of NO using BH4, a cofactor involved in NO production, is a novel therapy for improving oxygenation and metabolism in these patients. Patients with COPD performed dynamic plantar flexion exercise with 31P-MRS and vascular Doppler ultrasound assessments following supplementation of BH4. Limb blood flow during exercise was unchanged, however, exercise-induced changes in metabolic measurements were improved with BH4 supplementation. Therefore, BH4 supplementation in patients with COPD appears a promising therapy to improve muscle metabolism.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords